Markets:

Overview

News

Currencies

International

Treasuries

Crinetics Pharmaceuticals, Inc. - Common Stock (NQ:CRNX)

34.91 +0.44 (+1.26%)

Streaming Delayed Price Updated: 3:16 PM EDT, Jun 15, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Crinetics Pharmaceuticals, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 Next >

Crinetics Pharmaceuticals to Present Corporate and Clinical Update at 41st Annual J.P. Morgan Healthcare Conference

January 09, 2023

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals's Return On Capital Employed Overview ↗

December 26, 2022

Via Benzinga

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

December 12, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals Provides Update on CRN04777 Program

November 28, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics' CRN04777 Shows Dose-Dependent Suppression of Fasting Insulin ↗

March 31, 2022

Via Benzinga

Crinetics Pharmaceuticals to Participate in the 5th Annual Evercore ISI HealthCONx Conference

November 22, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals Reports Third Quarter 2022 Financial Results and Provides Corporate Update

November 14, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

November 10, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Enrollment Completed in Phase 3 PATHFNDR-1 Study Evaluating Oral Paltusotine for the Treatment of Acromegaly

October 13, 2022

Topline results for PATHFNDR-1 study expected in Q3 2023

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

October 10, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Innovation Passport Granted for CRN04777 for the Treatment of Congenital Hyperinsulinism

October 06, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals Appoints Dana Pizzuti, M.D. as Chief Development Officer

October 03, 2022

From Crinetics Pharmaceuticals, Inc.

Via GlobeNewswire

Crinetics Pharmaceuticals's Return On Capital Employed Overview ↗

September 09, 2022

Benzinga Pro data, Crinetics Pharmaceuticals (NASDAQ:CRNX) reported Q2 sales of $439 thousand. Earnings fell to a loss of $42.38 million, resulting in a 22.38% decrease from last quarter.

Via Benzinga

Crinetics Pharmaceuticals: Q2 Earnings Insights ↗

August 12, 2022

Crinetics Pharmaceuticals (NASDAQ:CRNX) reported its Q2 earnings results on Friday, August 12, 2022 at 08:00 AM. Here's what investors need to know about the announcement.

Via Benzinga

88 Biggest Movers From Yesterday ↗

May 26, 2022

Gainers The Very Good Food Company Inc. (NASDAQ: VGFC) shares jumped 118.2% to close at $0.2950 on Wednesday as the company announced it increased retail distribution across Canada with Loblaw...

Via Benzinga

Crinetics Pharmaceuticals Announces Positive Top-line Results From CRN04894 Early-Stage Trial ↗

May 25, 2022

Crinetics Pharmaceuticals Inc (NASDAQ: CRNX) revealed positive topline results from a first-in-human Phase 1 clinical study of CRN04894 for the treatment of patients with Cushing's disease.

Via Benzinga

The Daily Biotech Pulse: Third FDA Rejection For Verrica's Skin Disease Drug, Assembly Bio Terminates Hepatitis B Virus Pact, Consistency Data For Valneva's Chikungunya Vaccine ↗

May 25, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours.

Via Benzinga

The Daily Biotech Pulse: GlaxoSmithKline And Halozyme Go Shopping, Mylan's Insulin Glargine Recall, Turning Point Shares Lung Cancer Data And More ↗

April 13, 2022

Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Halozyme Buys Specialty Product Company Antares In $960M Deal

Via Benzinga

12 Health Care Stocks Moving In Friday's Intraday Session ↗

November 26, 2021

Gainers iSpecimen (NASDAQ:ISPC) stock moved upwards by 115.09% to $21.94 during Friday's regular session. As of 12:30 EST, this security is trading at a volume of 62.8...

Via Benzinga

53 Biggest Movers From Yesterday ↗

April 01, 2022

Gainers Longeveron Inc. (NASDAQ: LGVN) shares jumped 105.4% to close at $13.80 on Thursday after the company announced the publication of results from a Phase 1 trial testing...

Via Benzinga

10 Biggest Price Target Changes For Monday ↗

November 08, 2021

Barclays cut Deciphera Pharmaceuticals, Inc. (NASDAQ:

Via Benzinga

Last Week's Notable Insider Buys: Beacon Roofing Supply, Enfusion, Nerdy And More ↗

October 30, 2021

Insider buying can be an encouraging signal for potential investors, especially when markets are uncertain or near highs. Beneficial owners made some the most notable insider...

Via Benzinga

52 Biggest Movers From Yesterday ↗

December 01, 2021

Gainers Cumberland Pharmaceuticals Inc. (NASDAQ: CPIX) shares climbed 128.6% to close at $5.03 on Tuesday. The FDA approved expanded labeling for Cumberland...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

October 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) stock moved upwards by 22.79% to $2.64 during Thursday's regular session. The current volume of 17.1 million shares is 2411.03...

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For November 30, 2021 ↗

November 30, 2021

Upgrades Sidoti & Co. upgraded the previous rating for DMC Global Inc (NASDAQ:

Via Benzinga

38 Stocks Moving In Thursday's Mid-Day Session ↗

October 21, 2021

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares jumped 132.3% to $23.14 following an announcement the company will merge with Trump Media & Technology Group....

Via Benzinga

Topics Government

Benzinga's Top Ratings Upgrades, Downgrades For November 23, 2021 ↗

November 23, 2021

Upgrades Keefe, Bruyette & Woods upgraded the previous rating for CBRE Group Inc (NYSE:

Via Benzinga

54 Biggest Movers From Yesterday ↗

October 22, 2021

Gainers Digital World Acquisition Corp. (NASDAQ: DWAC) shares climbed 356.8% to close at $45.50 on Thursday following an announcement the company will merge with Trump Media...

Via Benzinga

Topics Government

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

October 21, 2021

Gainers Sio Gene Therapies (NASDAQ:SIOX) shares rose 13.95% to $2.45 during Thursday's pre-market session. The market value of their outstanding shares is at $178.7...

Via Benzinga

The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO ↗

October 21, 2021

Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine...

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.